These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15997485)

  • 41. Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
    Venugopal AA; Riederer K; Patel SM; Szpunar S; Jahamy H; Valenti S; Shemes SP; Khatib R; Johnson LB
    Scand J Infect Dis; 2012 Apr; 44(4):243-9. PubMed ID: 22077148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clostridium difficile-associated diarrhea in adults.
    Poutanen SM; Simor AE
    CMAJ; 2004 Jul; 171(1):51-8. PubMed ID: 15238498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of Clostridium difficile-associated diarrhea.
    Malnick SD; Zimhony O
    Ann Pharmacother; 2002 Nov; 36(11):1767-75. PubMed ID: 12398575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid.
    Norén T; Wullt M; Akerlund T; Bäck E; Odenholt I; Burman LG
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3028-32. PubMed ID: 16940098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent changes in Clostridium difficile infection.
    Silva Júnior M
    Einstein (Sao Paulo); 2012; 10(1):105-9. PubMed ID: 23045838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes from rectal vancomycin therapy in patients with Clostridium difficile infection.
    Saffouri G; Khanna S; Estes L; Pardi D
    Am J Gastroenterol; 2014 Jun; 109(6):924-5. PubMed ID: 24896763
    [No Abstract]   [Full Text] [Related]  

  • 47. Clostridium difficile and the disease it causes.
    Norén T
    Methods Mol Biol; 2010; 646():9-35. PubMed ID: 20597000
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preventing downstream Clostridium difficile infections with upstream antibiotic management.
    Malkan AD; Scholand SJ
    Med Hypotheses; 2012 Jan; 78(1):136-7. PubMed ID: 22079651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Editorial Commentary: the trials and tribulations of treating Clostridium difficile infection-one step backward, one step forward, but still progress.
    Wilcox MH
    Clin Infect Dis; 2014 Aug; 59(3):355-7. PubMed ID: 24799325
    [No Abstract]   [Full Text] [Related]  

  • 50. Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection?
    Kuijper EJ; Wilcox MH
    Clin Infect Dis; 2008 Jul; 47(1):63-5. PubMed ID: 18491959
    [No Abstract]   [Full Text] [Related]  

  • 51. Metronidazole resistance in Clostridium difficile.
    Johnson S; Sanchez JL; Gerding DN
    Clin Infect Dis; 2000 Aug; 31(2):625-6. PubMed ID: 10987742
    [No Abstract]   [Full Text] [Related]  

  • 52. Nosocomial diarrhoea in adult medical patients: the role of Clostridium difficile in a North Italian acute care teaching hospital.
    Sansone S; Aschbacher R; Staffler M; Bombonato M; Girardi F; Larcher C; Wiedermann CJ
    J Prev Med Hyg; 2009 Jun; 50(2):117-20. PubMed ID: 20099443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
    Bricker E; Garg R; Nelson R; Loza A; Novak T; Hansen J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004610. PubMed ID: 15674956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clostridium difficile--Associated diarrhea: A review.
    Mylonakis E; Ryan ET; Calderwood SB
    Arch Intern Med; 2001 Feb; 161(4):525-33. PubMed ID: 11252111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New and emerging therapies in treatment of Clostridium difficile infection.
    Goyal H; Perisetti A; Rehman MR; Singla U
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):589-597. PubMed ID: 29521664
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Past, present, and future therapies for Clostridium difficile-associated disease.
    Surowiec D; Kuyumjian AG; Wynd MA; Cicogna CE
    Ann Pharmacother; 2006 Dec; 40(12):2155-63. PubMed ID: 17148650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection.
    Cheng AC; Ferguson JK; Richards MJ; Robson JM; Gilbert GL; McGregor A; Roberts S; Korman TM; Riley TV;
    Med J Aust; 2011 Apr; 194(7):353-8. PubMed ID: 21470086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis.
    Hassoun A; Ibrahim F
    Am J Geriatr Pharmacother; 2007 Mar; 5(1):48-51. PubMed ID: 17608247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.
    Pépin J; Valiquette L; Alary ME; Villemure P; Pelletier A; Forget K; Pépin K; Chouinard D
    CMAJ; 2004 Aug; 171(5):466-72. PubMed ID: 15337727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clostridium difficile infection: a comprehensive review.
    Kachrimanidou M; Malisiovas N
    Crit Rev Microbiol; 2011 Aug; 37(3):178-87. PubMed ID: 21609252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.